Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 7 Sept 2026Clinical review pending
!
Severe pain may indicate invasive disease
Persistent deep ear pain, particularly at night, with diabetes, immunosuppression, canal granulation or a new facial weakness raises concern for necrotising otitis externa.
Action: Arrange same-day urgent ENT assessment; use emergency hospital care for neurological deficits, systemic illness or rapidly spreading infection. Do not simply extend a routine ear-spray course.
Synopsis
Identify diffuse canal inflammation and focal follicular infection, deliver effective topical treatment and recognise when pain or spread requires urgent specialist assessment.
Otitis externa affects the canal skin; pain on moving the tragus or pinna supports this location.
A furuncle is a focal infected hair follicle and small abscess in the outer hair-bearing canal.
Check the tympanic membrane and ask about perforation, grommets and previous ear surgery before selecting drops.
Key red flags
Disproportionate nocturnal otalgia or facial weakness in a person with diabetes or impaired immunity requires urgent ENT assessment for skull-base infection.
Investigation priorities
01
Otoscopy and external ear examinationFirst step
Localise the disease and assess treatment safety.
Management branches
Uncomplicated diffuse diseaseTreat the surface and enable delivery
Canal inflammation is present without invasive or spreading features.
Provide appropriate analgesia and choose a topical preparation after considering eardrum integrity, allergies and the likely inflammatory or infective process.
Explain the administration method and review whether drops can reach the affected canal; arrange skilled clearance or a wick if significant obstruction prevents delivery.
Key medicines
Acetic acid 2% ear spray for superficial diseaseEarCalm: one metered spray into each affected ear at least three times daily; maximum frequency one spray every 2–3 hours. Continue until two days after symptoms resolve, for no longer than seven days.
Dexamethasone 0.1% / neomycin 0.5% / acetic acid 2% ear sprayOne metered spray into each affected ear three times daily, continuing until two days after symptoms disappear. Stop and reassess if there is no clinical improvement after seven days; avoid prolonged unreviewed courses.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.
ENT UK outer ear infection informationNovember 2024 clinical presentation, treatment delivery, response and invasive warning features; product doses checked separately.